What processes were undertaken for the development of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD?
Overview of the process: This guideline adhered to international best practice for guideline development (Appendix B: Supplementary Tables S2 and S3).375,376 This guideline has been conducted and reported in accordance with the AGREE II reporting checklist.377 The processes undertaken for the development of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD are described below. The first step was to convene a Guideline Development Group (GDG) with expertise in nephrology, hypertension, pediatrics, nursing, and patient and public involvement. The GDG was responsible for developing the scope and the questions, conducting the systematic literature review, and formulating the recommendations. The GDG was supported by an independent Guideline Methodology Group (GMG). The GMG provided methodological expertise and guidance on the development of the guideline.